Market cap
$0 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
9.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.00 | -78.67 | -59.01 | -- | -- |
| EBIT | -198.56 | 79.37 | 72.47 | -245.64 | -197.25 |
| Net Profit | -194.46 | 80.52 | 72.29 | -247.60 | -186.21 |
| EPS | -147.19 | 89.27 | 80.56 | -13.99 | 13.66 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -12,486.81 | -12,486.81 | -3,061.21 | -2,716.95 | -6,474.88 |
| Net Margin
| -20,636.55 | 279,080.19 | -3,137.32 | -- | -12,054.14 |
| Return on equity
| -856.25 | -478.19 | -- | 199.39 | -2,186.15 |
| Return on Capital
| -397.47 | -150.95 | -- | 309.10 | -1,019.62 |
| Return on Assets
| -259.24 | -559.51 | -53.06 | -170.78 | -342.86 |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | -1.06 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
309.10
|
-1,019.62
|
-481.90
|
187.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
199.39
|
-2,186.15
|
-582.00
|
103.83
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
-53.06
Lower than Peers by 55.92
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
-53.06
|
-170.78
|
-342.86
|
-264.06
|
-1,230.11
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
-3,061.21
Lower than Peers by 3,077.03
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
-3,061.21
|
-2,716.95
|
-6,474.88
|
-28,268.59
|
--
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
-3,137.32
Lower than Peers by 3,145.55
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
-3,137.32
|
-2,793.87
|
-12,054.14
|
-29,218.97
|
1,164,300.00
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Revenue Growth
-59.01
Lower than Peers by 67.06
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
-59.01
|
-0.30
|
10.52
|
--
|
--
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
72.47
Higher than Peers by 64.20
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
72.47
|
70.66
|
-163.92
|
-886.11
|
18.74
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
72.29
Higher than Peers by 64.56
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
72.29
|
70.60
|
-162.91
|
-680.48
|
3.01
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
80.56
Higher than Peers by 70.16
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
80.56
|
0.69
|
-1.15
|
-2.42
|
0.06
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
-9.34
Lower than Peers by 14.22
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
-9.34
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
-1.06
|
--
|
-0.45
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
0.12
|
-0.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.09
Lower than Peers by 1.56
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
0.09
|
0.20
|
1.03
|
3.34
|
0.03
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
0.09
Lower than Peers by 1.11
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
0.09
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
-23.36
Lower than Peers by 28.13
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
-23.36
|
-23.41
|
-102.81
|
-66.02
|
-6.63
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.02
Lower than Peers by 0.38
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
0.02
|
0.06
|
0.05
|
0.01
|
--
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
--
|
671.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
-0.10
|
-0.98
|
-9.96
|
-0.95
|
|
Peer Median
|
37.31
|
--
|
--
|
--
|
--
|
Price / Book Value
9.20
Higher than Peers by 1.45
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
9.20
|
-0.15
|
-9.92
|
19.88
|
-0.77
|
|
Peer Median
|
7.75
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.42
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
0.42
|
0.04
|
-0.81
|
-9.50
|
-1.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 2,591
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Humanigen (HGEN)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,591
|
--
|
--
|
--
|
--
|